Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Earlier this week, Fiserv, Inc. (FISV - Analyst Report) declared that U.S. Bank, subsidiary of U.S. Bancorp (USB - Analyst Report), shall integrate its online banking platform with Fiserv’s Mobiliti Enterprise mobile banking and payments solutions. This venture would in turn merge with Apple, Inc.’s (AAPL - Analyst Report) iPad banking application platform for the bank’s customers.
This state-of-the-art technology shall not only make account balance checking, money transfer, bill payment services etc. easier and more convenient, but also enhance the entire customer service experience substantially. The burgeoning demand for tablets in today’s world shall further stimulate this strategy and turn out to be beneficial in the global economy.
Fiserv’s Mobiliti Enterprise solutions have the reputation of building and managing important banking solutions such as text banking, iPhone applications, etc. Hence, we believe that it befits a company with the goodwill and expertise of Fiserv to deserve a deal of this stature today.
The company appears to be in quite a favourable position with the recent financial results of its 2012 first quarter. Record revenues of around $1 billion were declared, rising nearly 5% annually. Furthermore, management provided an ambitious outlook for the full year, projecting annual revenue growth of 4% - 6%. Fiserv seems to be advancing strategically to make its full year expectations come true with ease.
The Zacks Consensus Estimates for the second quarter and fiscal 2012 stand at $1.26 per share and $5.17 per share, respectively. We currently have a long-term recommendation of ‘Neutral’ for the company’s stock. In the short run, we have a Zacks #3 Rank for the stock, which translates into a short-term rating of ‘Hold’.
Get the full Analyst Report on USB - FREE
Get the full Analyst Report on FISV - FREE
Get the full Analyst Report on AAPL - FREE